Author: Digonto Chatterjee

Marcia Wendorf writes that early adopters of M1 devices might have to suffer for a bit of time before developers catch up. M1 will need some time to catch up with gaming. Hopefully that will change as developers migrate their apps to the Arm architecture. Apple is well known for optimizing its software and hardware […]

Video games are now being approved for treatment of ADHD. The game can be legally marketed and sold as a medicine in the United States.  The game developed by Akili Interactive and called EndeavorRx, can be played on iPads or iPhones. It’s meant to be used for kids between eight and twelve years old with […]

Motion capture is the process of recording the movement of objects or people. It records actions of human actors, and uses that information to animate digital character models in 2D or 3D computer animation capture technology. It is widely used in the films or computer games. However, these technologies require expensive equipment and dozens of markers to be attached. Computer scientists from CAMERA the […]

Global Warming is a massive problem that many are working to solve around the world. Now scientists have found a way to help, by parking smarter. A new app that helps reduce congestion by helping drivers find the optimal route to their destination and connecting them to garages. Reducing congestion has been seen to reduce […]

With less chalkboards and more online instruction, making visual representations of mathematics is becoming more difficult. Thankfully, researchers at Carnegie Mellon have created the perfect solution. Using the tool titled Penrose, anyone can now translate the abstractions of mathematics into beautiful and instructive illustrations. Unlike a graphing calculator, these expressions aren’t limited to basic functions, […]

The RECOVERY (Randomized Evaluation of COVid-19 thERapY) trial was established as a randomized clinical trial to test several potential treatments for COVID-19, including low-dose dexamethasone (a a cheap and widely available steroid treatment). The study enrolled 2,100 participants who received dexamethasone at a low or moderate dose compared to compared how they fared against about […]